investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

FOXD3 Up-Regulation and ERBB3 Signaling as an Adaptive Response to RAF Inhibitors

Andrew E Aplin

1 Collaborator(s)

Funding source

National Cancer Institute (NIH)

Andrew E Aplin

Thomas Jefferson University

Philadelphia, United States

Thore Kettmann

U3 Pharma Gmbh

Martinsried, Germany

Related projects